Select Publications
Journal articles
2013, 'Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma', British Journal of Dermatology, 169, pp. 208 - 210, http://dx.doi.org/10.1111/bjd.12272
,2013, '713 ABIRATERONE ACETATE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WITHOUT PRIOR CHEMOTHERAPY - INTERIM ANALYSIS OF THE COU-AA-302 PHASE 3 TRIAL', Journal of Urology, 189, http://dx.doi.org/10.1016/j.juro.2013.02.272
,2013, '97 Updated interim analysis (IA): Results of randomized phase 3 study COU-AA-302 of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) without prior chemotherapy', European Urology Supplements, 12, pp. e97 - e98, http://dx.doi.org/10.1016/s1569-9056(13)60589-8
,2013, 'Abiraterone in metastatic prostate cancer without previous chemotherapy', New England Journal of Medicine, 368, pp. 138 - 148, http://dx.doi.org/10.1056/NEJMoa1209096
,2013, 'Bayesian methods for pharmacokinetic/pharmacodynamic modeling of pazopanib-induced increases in blood pressure and transaminases', Journal of Clinical Pharmacology, 53, pp. 377 - 384, http://dx.doi.org/10.1002/jcph.16
,2013, 'Current and potential treatments for cervical cancer', Current Cancer Drug Targets, 13, pp. 205 - 220, http://dx.doi.org/10.2174/1568009611313020009
,2013, 'Folate Conjugation to Polymeric Micelles via Boronic Acid Ester to Deliver Platinum Drugs to Ovarian Cancer Cell Lines', Biomacromolecules, 14, pp. 962 - 975, http://dx.doi.org/10.1021/bm400121q
,2012, 'CORRELATION OF GRADE & HORMONE-RECEPTOR STATUS WITH STAGE IN NODE-POSITIVE, NON-METASTATIC BREAST CANCER', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, pp. 335 - 335, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310544400357&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'USE OF CETUXIMAB AS AN ADJUVANT AGENT TO RADIOTHERAPY AND SURGERY IN RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA WITH SQUAMOUS CELL CARCINOMA', WOUND REPAIR AND REGENERATION, 20, pp. A60 - A60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'AN EXPLORATORY ANALYSIS OF THE LONGITUDINAL RELATIONSHIPS BETWEEN PROSTATE SPECIFIC ANTIGEN AND THE INFLAMMATORY MARKERS C-REACTIVE PROTEIN AND ERYTHROCYTE SEDIMENTATION RATE', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, pp. 58 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'PHASE III, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MODAFINIL FOR FATIGUE IN PATIENTS TREATED WITH DOCETAXEL-BASED CHEMOTHERAPY', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, pp. 44 - 44, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'TUMOUR:NODE RATIO IN NODE-POSITIVE, NON-METASTATIC BREAST CANCER', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, pp. 37 - 37, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Increase in cholesterol predicts survival advantage in renal cell carcinoma patients treated with temsirolimus', Clinical Cancer Research, 18, pp. 3188 - 3196, http://dx.doi.org/10.1158/1078-0432.CCR-11-3137
,2012, 'Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).', Journal of Clinical Oncology, 30, pp. LBA4518 - LBA4518, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.lba4518
,2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial.', Journal of Clinical Oncology, 30, pp. e15152 - e15152, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e15152
,2012, 'Phase I study of everolimus in combination with fluvastatin and zoledronic acid in patients with solid tumours.', Journal of Clinical Oncology, 30, pp. e13585 - e13585, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e13585
,2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial', JOURNAL OF CLINICAL ONCOLOGY, 30, http://dx.doi.org/10.1200/jco.2012.30.5_suppl.211
,2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial.', J Clin Oncol, 30, pp. 211, http://www.ncbi.nlm.nih.gov/pubmed/27967925
,2012, 'Biomarkers for tyrosine kinase inhibitors in renal cell cancer', Translational Andrology and Urology, 1, pp. 216 - 222, http://dx.doi.org/10.3978/j.issn.2223-4683.2012.10.01
,2012, 'Acid Degradable Cross-Linked Micelles for the Delivery of Cisplatin: A Comparison with Nondegradable Cross-Linker', Chemistry of materials, 24, pp. 3197 - 3211, http://dx.doi.org/10.1021/cm301556b
,2012, 'Association of Radiographic Progression-Free Survival (RPFS) Adapted from Prostate Cancer Working Group 2 (PCWG2) Consensus Criteria (APCWG2) with Overall Survival (OS) in Patients (PTS) with Metastatic Castration-Resistant Prostate Cancer (MCRPC): Results from COU-AA-302', Annals of Oncology, 23, pp. ix294 - ix295, http://dx.doi.org/10.1016/s0923-7534(20)33459-1
,2012, 'Block copolymer micelles with pendant bifunctional chelator for platinum drugs: Effect of spacer length on the viability of tumor cells', Biomacromolecules, 13, pp. 1010 - 1023, http://dx.doi.org/10.1021/bm2017299
,2012, 'Cancer-related fatigue in women with breast cancer: outcomes of a 5 year prospective cohort study.', Journal of Clinical Oncology, 30, pp. 1805 - 1812, http://dx.doi.org/10.1200/JCO.2011.34.6148
,2012, 'Concomitant use of pazopanib and simvastatin increases the risk of transaminase elevations in patients with cancer', Annals of Oncology, 23 Sep 2012, pp. 2470 - 2471, http://dx.doi.org/10.1093/annonc/mds249
,2012, 'Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study.', Asia-Pacific Journal of Clinical Oncology, 8, pp. 248 - 254, http://dx.doi.org/10.1111/j.1743-7563.2012.01540.x
,2012, 'Outcomes of Ethnic Minority Groups With Node-Positive, Non-Metastatic Breast Cancer in a Tertiary Referral Centre in Sydney', Annals of Oncology, 23, pp. ix100 - ix100, http://dx.doi.org/10.1016/s0923-7534(20)32823-4
,2012, 'Post-cancer fatigue is not associated with immune activation or altered cytokine production', Annals of Oncology, 23, pp. 2890 - 2895, http://dx.doi.org/10.1093/annonc/mds108
,2012, 'Randomized, Open-Label, Phase III Trial Of Pazopanib Versus Sunitinib In First-Line Treatment Of Patients With Metastatic Renal Cell Carcinoma (MRCC): Results of the Comparz Trial', Annals of Oncology, 23, pp. ixe13 - ixe13, http://dx.doi.org/10.1016/s0923-7534(20)34325-8
,2011, 'PRIMARY TREATMENT OF THE PROSTATE IMPROVES LOCAL PALLIATION IN MEN WHO ULTIMATELY DEVELOP CASTRATE RESISTANT PROSTATE CANCER.', JOURNAL OF ENDOUROLOGY, 25, pp. A256 - A257, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000296792201146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Genetic evaluation of fatigue in pazopanib-treated patients (pts) with advanced renal cell carcinoma (RCC).', J Clin Oncol, 29, pp. e15072, http://www.ncbi.nlm.nih.gov/pubmed/28020421
,2011, 'Bone health in prostate cancer', Expert Review of Endocrinology and Metabolism, 6, pp. 317 - 321, http://dx.doi.org/10.1586/eem.11.4
,2011, 'Ras isoprenylation and pAkt inhibition by zoledronic acid and fluvastatin enhances paclitaxel activity in T24 bladder cancer cells', Cancers, 3, pp. 662 - 674, http://dx.doi.org/10.3390/cancers3010662
,2011, 'Conditions causing gemcitabine crystallization', Journal of Oncology Pharmacy Practice, 17, pp. 395 - 399, http://dx.doi.org/10.1177/1078155210385033
,2011, 'Functionalization of microspheres with malonates using Michael Addition as a pathway to create a drug delivery system for platinum drugs for the treatment of liver cancer', Polymer, 52, pp. 5993 - 6002, http://dx.doi.org/10.1016/j.polymer.2011.10.054
,2011, 'Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes', Journal of Clinical Oncology, 29, pp. 2557 - 2564, http://dx.doi.org/10.1200/JCO.2010.32.9110
,2011, 'Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer', BMC Clinical Pharmacology, 11, pp. 1 - 8, http://dx.doi.org/10.1186/1472-6904-11-1
,2011, 'Polymeric micelles with pendant dicarboxylato chelating ligands prepared via a michael addition for cis -platinum drug delivery', Macromolecules, 44, pp. 7888 - 7900, http://dx.doi.org/10.1021/ma2016503
,2010, 'A phase II trial of weekly i.v. KW-2170 in advanced castrate-resistant prostate cancer', Asia-Pacific Journal of Clinical Oncology, 6, pp. 292 - 297, http://dx.doi.org/10.1111/j.1743-7563.2010.01328.x
,2010, 'Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma', Journal of Urology, 184, pp. 1303, http://dx.doi.org/10.1016/j.juro.2010.06.075
,2010, 'Influence of fatigue after breast cancer adjuvant theraphy on health care utilization and percieved needs', JOURNAL OF CLINICAL ONCOLOGY, 28, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.9047
,2010, 'Randomized phase II trial of patupilone plus prednisone versus docetaxel plus prednisone in patients with chemotherapy-naive, metastatic, castrate-resistant prostate cancer(CRPC)', JOURNAL OF CLINICAL ONCOLOGY, 28, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.4553
,2010, 'Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma', Journal of Clinical Oncology, 28, pp. 475 - 480, http://dx.doi.org/10.1200/JCO.2008.21.6994
,2010, 'Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer.', Nutrition Reviews, 68, pp. 542 - 555, http://dx.doi.org/10.1111/j.1753-4887.2010.00314.x
,2010, 'Core-Crosslinked Micelles synthesized by Clicking Bifunctional Pt(IV) Anticancer Drugs to Isocyanates', Biomacromolecules, 11, pp. 2290 - 2299, http://dx.doi.org/10.1021/bm100396s
,2010, 'Emerging roles for phospholipase A2 enzymes in cancer', Biochimie, 92, pp. 601 - 610
,2010, 'Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer', Annals of Oncology, 21, pp. 1302 - 1307, http://dx.doi.org/10.1093/annonc/mdp524
,2010, 'Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-alpha', British Journal of Cancer, 102, pp. 1456 - 1460, http://dx.doi.org/10.1038/sj.bjc.6605647
,2009, 'Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor', Microbes and Infection, 11, pp. 435 - 442, http://dx.doi.org/10.1016/j.micinf.2009.01.004
,2009, 'Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells', British Journal of Cancer, 100, pp. 649 - 655, http://dx.doi.org/10.1038/sj.bjc.6604920
,2009, 'Analysis of PTEN and HIF-1 alpha and Correlation With Efficacy in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus Versus Interferon-alpha', Cancer, 115, pp. 3651 - 3660
,